Study on effect and mechanism of salidroside on cognitive ability of Aβ1-40-induced Alzheimer's disease model rats

Zhongguo Zhongyao Zazhi

Volumn 37, Issue 14, 2012, Pages 2122-2126

  Zhang, Jia ^a   Song, Ligang ^a   Kong, Weina ^b   Shao, Tiemei ^b   Wen, Xin ^b   Liu, Pei ^b   Chai, Xiqing ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI CHEMICAL AND PHARMACEUTICAL COLLEGE   (China)

Author keywords

Alzheimer's disease; Dementia; iNOS; NF B; RAGE; Salidroside

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN[1-40]; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; SALIDROSIDE; SUPEROXIDE DISMUTASE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; LATENT PERIOD; LEARNING; LIPID PEROXIDATION; MAZE TEST; MEMORY; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; TREATMENT DURATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; COGNITION; DISEASE MODELS, ANIMAL; GLUCOSIDES; MALE; MAZE LEARNING; NF-KAPPA B; NITRIC OXIDE; PHENOLS; RATS; RECEPTORS, IMMUNOLOGIC; SUPEROXIDE DISMUTASE;

EID: 84867616295     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20121419     Document Type: Article

References (16)

1. Hardy J, Selkoe D J. The amyloid hypothesis of Alzheimer's disease; progress and problems on the road to therapeutics[J]. Science, 2002, 297 (5580): 353.
2. Milton R H, Abeti R, Averaimo S, et al. CUC1 function is required for β-amyloid-induced generation of reactive oxygen species by microglia[J]. J Neurosci, 2008, 28 (45) : 11488.
3. Schubert D, Behl C, Lesley R, et al. Amyloid peptides are toxic via a common oxidative mechanism [J]. Proc Natl Acad Sci, 1995, 92 (6): 1989.
4. Morris R. Developments of a water maze procedure for studying spatial learning in the rat[J]. J Neurosci Methods, 1984, 11 (1): 47.
5. Seyidova D, Aliyev A, Rzayev N. The role of nitric oxide in the pathogenesis of brain lesions during the development of Alzheimer's disease[J]. In Vivo, 2004,18: 325.
6. Bloodsworth A, O'Donnell V B, Freeman B A, et al. Nitric oxide regulation of free radical-and enzyme-mediated lipid and lipoprotein oxidation[J]. Arterioscler Thromb Vasc Biol, 2000, 20: 1707.
7. Combs C K, Karlo J C, Kao S C, et al. β-Amyloid Stimulation of microglia and monocytes results in TNF-dependent expression of inducible nitric oxide synthase and neuronal apoptosis [J]. J Neurosci, 2001, 21(4): 1179.
8. Baldwin A J. Series introduction; the transcription factor NF-kappa B and human disease[J]. J Clin Invest, 2001, 107(1): 3.
9. Sturchler E, Galichet A, Weibel M, et al. Site-specific blockade of RAGE-Vd prevents amyloid-β oligomer neurotoxicity [J]. J Neurosci, 2008, 28(2/3) : 5149.
10. Yeh C H, Sturgis L, Haidacher J, et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-B transcriptional activation and cytokine secretion[J]. Diabetes, 2001, 50: 1495.
11. Mukherjee T K, Mukhopadhyay S, Hoidal J R. The role of reactive oxygen species in TNFalpha-dependent expression of the receptor for advanced glycation end products in human umbilical vein endothelial cells[J]. Biochim Biophys Acta, 2005, 1744 (2): 213.